Fig. 4From: A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemiaTKI switching. (a) TKI switch journey from 1 L to 6 L. Distribution based on initial TKI prescribed at diagnosis. (b) Number of switches until reaching DMR for the 3 most frequently used initial TKIs. Numbers above bars represent patients that achieved optimal response/DMR per total patients in that treatment groupBack to article page